Carlton Hofferkamp & Jenks Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Carlton Hofferkamp & Jenks Wealth Management, LLC

$285 Million
Q3 2025

A detailed history of Carlton Hofferkamp & Jenks Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carlton Hofferkamp & Jenks Wealth Management, LLC holds 5,345 shares of GILD stock, worth $635,199. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,345

Previous 5,595 4.47%

Holding current value

$635,199

Previous $620,000 4.35%

% of portfolio

0.21%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$108.22 - $120.47 $27,055 - $30,117	-250 Reduced 4.47%	5,345 $593,000
Q2 2025 Jul 31, 2025	SELL	$96.91 - $113.0 $24,712 - $28,815	-255 Reduced 4.36%	5,595 $620,000
Q4 2024 Feb 06, 2025	SELL	$83.95 - $97.9 $58,765 - $68,530	-700 Reduced 10.69%	5,850 $540,000
Q3 2024 Nov 05, 2024	SELL	$66.59 - $83.99 $13,318 - $16,798	-200 Reduced 2.96%	6,550 $549,000
Q1 2024 Apr 26, 2024	SELL	$71.58 - $87.29 $2,147 - $2,618	-30 Reduced 0.44%	6,750 $494,000
Q4 2023 Jan 25, 2024	SELL	$73.27 - $83.09 $7,327 - $8,309	-100 Reduced 1.45%	6,780 $549,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $15,962 - $18,207	-210 Reduced 2.96%	6,880 $530,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $38,655 - $44,040	-500 Reduced 6.59%	7,090 $588,000
Q4 2022 Jan 30, 2023	SELL	$62.32 - $89.47 $37,392 - $53,682	-600 Reduced 7.33%	7,590 $651,000
Q1 2022 Apr 11, 2022	BUY	$57.92 - $72.58 $14,480 - $18,145	250 Added 3.15%	8,190 $510,000
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $8,109 - $9,205	125 Added 1.6%	7,940 $547,000
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $9,138 - $9,859	135 Added 1.76%	7,815 $516,000
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $19,041 - $20,805	300 Added 4.07%	7,680 $527,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $63,300 - $72,225	1,055 Added 16.68%	7,380 $477,000
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $201,107 - $229,152	-3,550 Reduced 35.95%	6,325 $424,000
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $23,287 - $29,280	375 Added 3.95%	9,875 $593,000
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $249,573 - $289,800	3,450 Added 57.02%	9,500 $694,000
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $228,599 - $292,803	-3,650 Reduced 37.63%	6,050 $503,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $101,673 - $111,837	1,650 Added 20.5%	9,700 $619,000
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $18,753 - $20,700	300 Added 3.87%	8,050 $509,000
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $18,561 - $20,814	300 Added 4.03%	7,750 $519,000
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $427,680 - $473,520	-6,000 Reduced 44.61%	7,450 $575,000
Q2 2018 Jul 06, 2018	BUY	$64.88 - $75.68 $872,635 - $1.02 Million	13,450 New	13,450 $944,000

Others Institutions Holding GILD

# of Institutions

2,362

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.11M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $149B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlton Hofferkamp & Jenks Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carlton Hofferkamp & Jenks Wealth Management, LLC with notifications on news.

Account

Carlton Hofferkamp & Jenks Wealth Management, LLC Gilead Sciences, Inc. Transaction History